SOAT1 and myeloproliferative disorder: Jak-STAT dysregulating pharmaceuticals are used to fight autoimmune disorders such as rheumatoid arthritis, ulcerative colitis, Crohn disease, myelofibrosis, polycythemia vera, and other myeloproliferative diseases (70, 71).